Microsoft word - white lithium grease, 16 partmsds

H.M.I.S.
WHITE LITHIUM GREASE
STOCK # ('S): 24205, 24214, 24216, 24235, 24255
MATERIAL SAFETY DATA SHEET
Section 1- Chemical Product and Company Identification
Manufacture: Anti-Seize Technology
2345
Phone: 847-455-2300
Emergency Phone, 24 hr:
Infotrac @ 1-800-535-5053
Section 2-Composition/ Information on Ingredients
Section 3- Hazard Identification
ROUTES OF ENTRY: __X__ SKIN _____ EYES ______ INHALATION _____ INGESTION
HEALTH HAZARDS:
THIS PRODUCT IS PRACTICALLY NON TOXIC AND NON- IRRITATING. HOWEVER AS WITH ANY PETROLEUM
PRODUCT, AVOID PROLONGED OR REPEATED SKIN CONTACT.

Section 4 – First Aid Measures
SKIN: WASH WITH SOAP AND WATER, USING A NAIL BRUSH. PAY PARTICULAR ATTENTION TO FINGERNAILS AND OPEN
WOUNDS.
EYES: FLUSH EYE WITH WATER FOR 15 MINUTES, LIFTING THE EYELIDS. IF IRRITATION PERSISTS, CONSULT A PHYSICIAN.
INGESTION: IF INGESTED THIS PRODUCT IS NOT EXPECTED TO CAUSE AN ACUTE REACTION. THIS PRODUCT CONTAINS
PETROLEUM OIL; DO NOT INDUCE VOMITING, BECAUSE THE OIL MAY BE ASPIRATED INTO THE LUNGS. USE A GASTRIC LAVAGE,
AND CALL A POISON CONTROL CENTER OR A PHYSICIAN.
INHALATION: NOT LIKELY UNDER NORMAL CONDITIONS OF USE. IF USING IN HIGH TEMPERATURE APPLICATIONS WHERE
THERMAL DECOMPOSITION IS LIKELY, USE A LOCAL EXHAUST TO REMOVE FUMES. IF DIZZINESS OR IRRITATION OCCURS,
SEEK FRESH AIR.
CHEMICAL ('S) LISTED AS CARCINOGENS
NPT? NO I.A.R.C. ? : NO OSHA? : NO

Section 5 – Fire Fighting Measures
FLASH POINT AND METHOD USED: 460 F. C.O.C.
FLAMMABLE LIMITS: LEL: NO DATA UEL: NO DATA
EXTINGUISHING MEDIA: FOAM, CO2, DRY CHEMICAL
SPECIAL FIRE FIGHTING PROCEDURES: THIS COMPOUND WILL NOT BURN UNLESS IT IS PRE-HEATED. WATER FOG MAY BE
USED TO COOL THE CONTAINERS BUT DO NOT SPRAY DIRECTLY INTO LARGE CONTAINERS OF BURNING LIQUIDS AS
FROTHING MAY OCCUR. WEAR A “N.I.O.S.H" APPROVED ORGANIC VAPOR RESPIRATOR.
UNUSUAL FIRE AND EXPLOSION HAZARDS: DENSE SMOKE AND NOXIOUS OR TOXIC FUMES MAY BE GENERATED IN A FIRE.
FIRE FIGHTERS SHOULD WEAR A SELF-CONTAINED BREATHING APPARATUS.
Section 6 – Accidental Release Measures
SPILL/ LEAKAGE PROCEDURES: THE VISCOUS NATURE OF THIS PRODUCT MAKES SPILLS UNLIKELY. SCOOP UP THE MATERIAL
AND RETURN TO ITS ORIGINAL CONTAINER, OR USE AN OIL ABSORBENT MATERIAL AND DISPOSE OF PROPERLY.
Section 7 – Handling and Storage
PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE: STORE IN CLOSED CONTAINERS AWAY FROM INTENSE HEAT OR
OPEN FLAMES.
OTHER PRECAUTIONS: DO NOT TRANSFER TO UNMARKED CONTAINERS. KEEP AWAY FROM CHILDREN
Section 8 – Exposure Controls / Personal Protection
RESPIRATORY PROTECTION: NORMALLY NOT REQUIRED. IF THIS PRODUCT IS BEING USED IN HIGH TEMPERATURE
APPLICATIONS, WHERE THE PRODUCT "SMOKES", USE A LOCAL EXHAUST OR VENTILATE THE AREA TO MAINTAIN THE AIR
QUALITY. A "N.I.O.S.H." APPROVED ORGANIC VAPOR RESPIRATOR IS ALSO ACCEPTABLE.
PROTECTIVE GLOVES: NORMALLY NOT REQUIRED UNLESS PROLONGED OR REPEATED SKIN CONTACT IS EXPECTED, AND
THEN USE LATEX OR NEOPRENE GLOVES.
EYE PROTECTION: SAFETY GLASSES ARE RECOMMENDED.
WORK/HYGIENIC PRACTICES: USE GOOD STANDARD PRACTICES WHEN USING THIS MATERIAL. DO NOT EAT OR SMOKE WHILE
USING, AND THOROUGHLY WASH WITH SOAP AND WATER, USING A NAIL BRUSH AFTER USING.
Section 9 – Physical and Chemical Properties
BOILING POINT: > 600 F
SOLUBILITY IN WATER: NIL
MELTING POINT:
REACTIVITY IN WATER: NONE
VAPOR PRESSURE: NO DATA
SPECIFIC GRAVITY: 0.9
EVAPORATION RATE:
PERCENT VOLATILE: 0
APPEARANCE AND ODOR: WHITE COLORED GREASE, PETROLEUM LIKE ODOR.
Section 10 – Stability and Reactivity
STABILITY: (X) STABLE ( ) UNSTABLE
CONDITIONS TO AVOID:
NONE REASONABLE FORESEEN
INCOMPARABILITY, (MATERIALS TO AVOID): STRONG OXIDIZING AGENTS.
HAZARDOUS DECOMPOSITION PRODUCTS: THE THERMAL DECOMPOSITION PRODUCTS ARE HIGHLY DEPENDENT UPON THE
COMBUSTION CONDITIONS. NOXIOUS OR TOXIC FUMES MAY BE GENERATED, SOME OF WHICH MAY BE TOXIC OR IRRITATING.
HAZARDOUS POLYMERIZATION: WILL NOT OCCUR.
Section 11 – Toxicological Information
SEE SECTION 2 FOR ADDITIONAL INFORMATION Section 12 – Ecological Information
NO INFORMATION AVAILABLE. NOT EXPECTED TO BIOACCUMULATE. Section 13 – Disposal Consideration
WASTE DISPOSAL: DISPOSE OF IN A RESPONSIBLE MANNER. FOLLOW LOCAL, STATE AND FEDERAL GUIDELINES. DO NOT
DISCHARGE INTO SEWERS OR WATERWAYS. INCINERATION IS THE PREFERRED METHOD OF DISPOSAL, ALTHOUGH IT MAY BE
LANDFILLED AT AN APPROVED FACILITY.
Section 14- Transport Information
TRANSPORTATION BY LAND (49CFR): NO RESTRICTIONS

TRANSPORTATION BY AIR (ICAO / IATA):
NO RESTRICTIONS
TRANSPORTATION BY SHIP (IMO/IMDG);
NO RESTRICTIONS

WHMIS:
NOT REGULATED
Section 15 – Regulatory Information
CALIFORNIA PROPOSITION 65: NO
OZONE DEPLETING SUBSTANCES: NONE
DOT SHIPPING CLASS: NOT HAZARDOUS
SARA TITLE III: NO
TASCA INVENTORY: ALL INGREDIENTS LISTED
CERCLA: NO
N.F.P.A. RATING: H-1, F-2, R-0
Section 16 – Other Information:
THE INFORMATION CONTAINED HEREIN IS BASED ON DATA CONSIDERED ACCURATE, HOWEVER, NO WARRANTY IS
EXPRESSED OR IMPLIED REGARDING THE ACCURACY OF THE DATA OR THE RESULTS OBTAINED FROM THE USE OF HIS
PRODUCT. THEREFORE, BECAUSE THE PRODUCT MAY BE USED UNDER CONDITIONS BEYOND OUR CONTROL, WE ASSUME NO
LIABILITY FOR ITS USE.
DATE: 1/22/2009
WHITE LITHIUM GREASE, 16 PART ISO MSDS

Source: http://www.multi-craft.net/wp/wp-content/uploads/2011/03/ANTI-SEIZE-TECHNOLOGY-WHITE-LITHIUM-GREASE.pdf

1cairn.info

LES ENTOURAGES DE PHILIPPE PÉTAIN, CHEF DE L'ETAT FRANÇAIS, 1940-1942 Jérôme Cotillon Presses de Sciences Po | Histoire@Politique 2009/2 - n° 08 pages 81 à 81 ISSN 1954-3670 Article disponible en ligne à l'adresse: -------------------------------------------------------------------------------------------------------------------- http://www.cairn.info/revue-histoire-p

Abordaje farmacolÓgico del paciente agitado

ABORDAJE FARMACOLÓGICO DEL PACIENTE AGITADO Comisión de Farmacia y Terapéutica X.A.P de Santiago 1. AGITACIÓN ORGÁNICA Deben extremarse las precauciones por los riesgos que supone administrar a un paciente médicamente grave un depresor del SNC. Mientras se resuelve la causa de la agitación, se puede recurrir a la sedación - De primera elección: Haloperidol , 2.5-5 mg IM, re

Copyright © 2010 Health Drug Pdf